Additionally, in a prospective follow-up of these patients with MSA, we found that higher baseline cystatin C levels could predict a higher risk of cognitive decline after accounting for potential confounders, including age, sex, educational years, disease duration, diagnosis subtype, OH, eGFR, and baseline MoCA score. Here, CST3 is linked to multiple system atrophy.